Ruffer LLP bought a new position in shares of Genpact Limited (NYSE:G - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 147,560 shares of the business services provider's stock, valued at approximately $6,494,000. Ruffer LLP owned approximately 0.08% of Genpact as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently bought and sold shares of G. Sumitomo Mitsui Trust Group Inc. purchased a new position in Genpact in the 1st quarter worth approximately $115,807,000. Clark Capital Management Group Inc. purchased a new position in Genpact in the 1st quarter worth approximately $64,842,000. Ameriprise Financial Inc. boosted its holdings in Genpact by 109.8% in the 1st quarter. Ameriprise Financial Inc. now owns 1,615,220 shares of the business services provider's stock worth $81,375,000 after acquiring an additional 845,393 shares during the period. JPMorgan Chase & Co. boosted its holdings in Genpact by 20.9% in the 1st quarter. JPMorgan Chase & Co. now owns 4,111,340 shares of the business services provider's stock worth $207,129,000 after acquiring an additional 710,704 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its stake in shares of Genpact by 421.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 767,386 shares of the business services provider's stock valued at $38,662,000 after buying an additional 620,201 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities analysts have recently commented on G shares. Deutsche Bank Aktiengesellschaft started coverage on Genpact in a research note on Thursday, July 17th. They set a "hold" rating and a $47.00 target price for the company. JPMorgan Chase & Co. reduced their target price on Genpact from $55.00 to $50.00 and set a "neutral" rating for the company in a research note on Wednesday, August 20th. Needham & Company LLC increased their target price on Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a research note on Friday, August 8th. Wall Street Zen lowered Genpact from a "buy" rating to a "hold" rating in a research report on Friday, September 5th. Finally, Mizuho upped their price target on Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research report on Tuesday, July 1st. Three investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of "Hold" and a consensus price target of $52.29.
View Our Latest Analysis on Genpact
Genpact Price Performance
Shares of NYSE G opened at $42.73 on Thursday. Genpact Limited has a 1-year low of $37.82 and a 1-year high of $56.76. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.53 and a quick ratio of 1.53. The business's fifty day moving average price is $43.87 and its two-hundred day moving average price is $45.33. The firm has a market capitalization of $7.45 billion, a PE ratio of 14.20, a P/E/G ratio of 1.41 and a beta of 0.92.
Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.03. Genpact had a return on equity of 22.15% and a net margin of 10.92%.The firm had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same period last year, the company earned $0.79 earnings per share. The firm's revenue for the quarter was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. On average, research analysts expect that Genpact Limited will post 3.21 EPS for the current year.
Genpact Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be given a $0.17 dividend. The ex-dividend date of this dividend is Thursday, September 11th. This represents a $0.68 annualized dividend and a yield of 1.6%. Genpact's dividend payout ratio (DPR) is currently 22.59%.
Insider Buying and Selling at Genpact
In other news, CEO Balkrishan Kalra sold 55,000 shares of the firm's stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the transaction, the chief executive officer directly owned 295,246 shares of the company's stock, valued at approximately $12,801,866.56. This trade represents a 15.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Piyush Mehta sold 76,902 shares of the firm's stock in a transaction on Friday, September 12th. The shares were sold at an average price of $42.58, for a total value of $3,274,487.16. Following the transaction, the senior vice president directly owned 134,880 shares in the company, valued at $5,743,190.40. This trade represents a 36.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.07% of the stock is owned by company insiders.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report